Discovery of a Carbamoyl Phosphate Synthetase 1–Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis
Tong Wu(Second Military Medical University), Lei Chen(Ministry of Education of the People's Republic of China), Jin Gu(Tsinghua University), Chengjun Sui(Second Military Medical University), Ji Hu(Second Military Medical University), Bo Zheng(Fifth Hospital of Shijiazhuang), Jing Tang(Union Hospital), Xinyao Qiu(Second Military Medical University), Yan Zhao(Fudan University), Yangqianwen Zhang(Second Military Medical University), Guijuan Luo(Second Military Medical University), Jianmin Wu(Fudan University), Jinxia Bao(Second Military Medical University), Qiuyu Lian(Shanghai Jiao Tong University), Siyun Shen(Second Military Medical University), Kaiting Wang(Fudan University), Wenwen Wang(Shanghai Medical College of Fudan University), Yang Zhao(Beijing Proteome Research Center), Hongyang Wang(Second Military Medical University), Zhixuan Li(Sun Yat-sen University), Yanjing Zhu(Second Military Medical University), Shan Wang(Fudan University Shanghai Cancer Center), Xuan Wu(Sichuan University), Yani Zhang(Second Military Medical University), Shuai Yang(Sichuan Agricultural University)
Cited by 65
Related Papers
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
|Nature Communications|2018|1k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|977
Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing
|Cell Discovery|2020|786
Comprehensive analysis of spatial architecture in primary liver cancer
|Science Advances|2021|359